Nicotine Vaccination

This new drug works by stimulating the production of antibodies in the blood. The antibodies stop nicotine from entering the brain and producing the addictive sensation craved by smokers.

The medical product has been fully effective on 50% of the 341 heavy smokers who took part in the study conducted by the Swiss pharmaceutical company Cytos Biotechnology.

Soon the world’s 1.3 billion smokers might have a powerful new way to kick the habit. The vaccine approach has the potential to dramatically alter the way we will treat smoking addiction in the future.

Learn More

How to Quit Smoking

Connect with Us

Communicate with us and follow our updates on your preferred social network.

This website uses cookies to improve the browsing experience. Continuing navigation without changing your browser settings, you agree to receive website cookie. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.